Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboprost or Oxytocin Postpartum Haemorrhage Effectiveness Study
2018-001829-11Phase 4Unknown
- Sponsor
- University of Liverpool
- Start
- Nov 2019
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postpartum hemorrhage (PPH) comparing Carboprost first-line arm with Oxytocin first-line arm (2 arms). Primary endpoint: Blood transfusion within 48 hours of birth. Status: unknown.
02
Drugs
carboprostoxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on 2018-001829-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001829-11.